Published on 29 Apr 2024 on Zacks via Yahoo Finance
Amgen AMGN will report first-quarter 2024 results on May 2, before market open. In the last reported quarter, the company beat earnings expectations by 1.07%.
Factors to Consider
Amgen’s product sales are expected to be the lowest in the first quarter per historical trends due to the impact of benefit plan changes, insurance re-verification and increased co-pay expenses as U.S. patients work through deductibles. First-quarter 2024 total revenues are expected to grow roughly 20% year over year. The Zacks Consensus Estimate for total revenues is $7.38 billion.